Moderna seeks to dismiss Covid-19 vaccine patent lawsuit

Modern Inc. is trying to push back against rival companies’ claims that its Covid-19 vaccine infringes their patents, arguing that the companies cannot pursue their claims by seeking royalties from the federal government.

Moderna on Friday filed a motion to dismiss some of the patent infringement claims in the lawsuit, which was filed in February by two small biotech companies, Arbutus Biopharma Corp. and Genevant Sciences GmbH, in federal court in Delaware.


Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button